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Summary 
Precursor cells differentiate into mature CD4 + and CD8 + T  cells in the inductive environment 
of the thymus by undergoing a series  of distinct developmental steps marked by expression of 
the  coreceptor molecules CD4  and  CD8.  Among  the  earliest  cells to  enter  the  CD4/CD8 
developmental  pathway  are  CD4-CD8 l~ precursors  cells  that  differentiate  into  CD4+CD8 + 
thymocytes. Here we show that differentiation of precursor cells into CD4 + CD8 + thymocytes 
requires at least one cell division and that  their progression through  a cell cycle is specifically 
retarded in the thymus by interaction with thymic epithelial cells that express transforming growth 
factor fl (TGF-fl) proteins. We also demonstrate that TGF-fl proteins, either in solution or bound 
to  cell  membranes,  can  regulate  cell  cycle progression  and  differentiation  of CD4-CD81~ 
precursor  cells into  CD4+CD8 + thymocytes.  The  regulatory  effect of TGF-B is specific  for 
CD4-CD8 l~ precursor  cells  as  TGF-fl  proteins  do  not  regulate  the  earlier  generation  of 
CD4-CD81~ precursor cells from CD4-CD8-  thymocytes. Finally, we demonstrate that TGF-fl 
proteins are expressed in vivo in the intact thymus on subcapsular and cortical thymic epithelium 
where they can contact  developing CD4-CD81~ precursor cells.  Thus,  thymic epithelial  cells 
expressing TGF-~ proteins can actively regulate the rate at which CD4 +  CD8 § thymocytes are 
generated from CD4-CD8 l~ precursor cells. 
M 
ature T  cells expressing TCR-odfl arise from TCR- 
. precursor  cells  in  the inductive  environment  of the 
thymus. Differentiation of precursor cells into mature T cells 
proceeds via a series of distinct steps that are defined by levels 
of expression of the CD4 and CD8 coreceptor molecules (1-3), 
referred to as the CD4/CD8 developmental pathway. Imma- 
ture  precursor  cells  that  express  neither  CD4  nor  CD8 
(CD4-CDS-)  enter the CD4/CD8 developmental pathway 
by first expressing low levels  of CD8  (4-9).  These CD4- 
CD81~ cells  are  the  immediate  precursors  of CD4+CD8 + 
thymocytes, the cell type in which most repertoire selection 
events are thought to occur (10-13). Upon being positively 
selected, CD4+CD8 + thymocytes extinguish expression of 
one coreceptor molecule and differentiate into mature CD4 + 
or CD8 + T  cells (14-17). Whereas little is known about the 
signals responsible for committing CD4 +  CD8 § thymocytes 
to become either CD4 § or CD8 + T cells (18-23), even less 
is known about the mechanisms regulating CD4 and CD8 
expression in early precursor thymocytes differentiating along 
the CD4/CD8  development  pathway. 
The first cells in the thymus that can be identified as having 
entered  the CD4/CD8  developmental pathway are CD4- 
CD81~ precursor cells  that  are transcriptionally  committed 
to becoming  CD4 +CD8 §  thymocytes,  and spontaneously 
do so when placed in single cell suspension culture. Despite 
their  commitment  to becoming  CD4+CD8 +,  differentia- 
tion of CD4-CD81~ precursor cells into CD4+CD8 + thy- 
mocytes can be actively inhibited by TCR engagement which 
signals the posttranscriptional  elimination  of mRNA spe- 
des encoding two families of developmentally important mol- 
ecules: (a) CD4 and CD8 coreceptor molecules, and (b) RAG-1 
and RAG-2 recombination activating molecules (24). Con- 
sequently, this TCR.-mediated regulatory mechanism func- 
tions in CD4-CD8 l~ precursor cells to abort further devel- 
opment along the CD4/CD8 developmental pathway of early 
thymocytes expressing  autoreactive  TCR  specific  for  self- 
antigens  (25). 
In this study, we have identified a novel regulatory mecha- 
nism that acts on all developing CD4-CD8 l~ precursor cells 
independently of their TCR specificity and that is mediated 
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progression through  at least one cell cycle is necessary for 
differentiation  of CD4-CD8 l~ precursor  cells  into  CD4 § 
CD8 + thymocytes, and that their progression through the 
cell cycle is specifically regulated by interaction with cortical 
TE cell lines. Furthermore, we found that inhibitory TE cells 
express TGF-B1 and TGF-~2 proteins which regulate the rate 
at which CD4-CD8 l~ precursor cells can progress through 
the cell cycle. In addition, we found that the regulatory effects 
of TGF-B proteins on early thymocyte development are stage 
specific in that  they do not affect the generation of CD4- 
CD8 ~~ cells from CD4- CD8 -  precursors. Finally, we found 
that TGF-B1 and TGF-/32 are primarily expressed by subcap- 
sular and cortical thymic epithelium in vivo precisely in those 
areas of the thymus in which CD4-CD81~ precursor thymo- 
cytes are located. Thus, this study demonstrates that interac- 
tion of lymphoid precursors with cortical TE cells expressing 
TGF-B proteins can regulate the rate at which early thymo- 
cyte development proceeds. 
Materials  and  Methods 
Mice.  C57BL/6 (B6) mice were obtained from the National 
Cancer Institute. Fetal mice were obtained from time pregnancies 
at gestational times as indicated. 
mAbs and Reagents.  FITC-anti-CD4 (Rm4-4 and Rm4-5) and 
anti-TCR-~ (H57-597) mAb were obtained from Pharmingen (San 
Diego, CA). FITC-conjugated and biotinylated anti-CD8 (53-6- 
72) mAb, as well as anti-human Leu4 negative control mAbs were 
obtained from Becton Dickinson Immunocytometry  Systems (BDIS, 
San Jose, CA). All reagents were pretitrated and used in saturating 
amounts. Nocodazole and PMA were obtained from Sigma Chem- 
ical Co. (St. Louis, MO). Recombinant human TGF-/~/1, recom- 
binant mouse TNF-o~, recombinant human Ib8, and anti-human 
TGF-~I Ab were obtained from R&D Systems, Inc. (Minneapolis, 
MN). Recombinant human TGF-~/2 and TGF-~/3 were provided 
by Dr. M.  Sporn at the National Institutes of Health. 
Cell Lines.  Cortical TE cell lines utilized were TEP1 (26), TEC 
(27), and 1308.1 (28,  29).  Medullary TE cell lines utilized were 
TE71 (30), Z172, Z199R, and Z210 derived from a normal BALB/c 
thymus (Farr, A., unpublished observations). Also utilized were 
the keratinocyte line PAM212 (31) and the L cell fibroblast  line 
DAP.3  (32). 
Cell Preparations and Culture.  Preparation of precursor thymo- 
cytes was described previously (24). For isolation of CD4-  thymo- 
cytes, single cell suspensions of fetal thymocytes were treated with 
IgM anti-CD4 mAb RL172 plus C. For isolation of purified popu- 
lations of CD4-CD8 * fetal thymocytes, CD4-  thymocytes were 
stained with anti-CD8 mAb, and CD8 + cells were sorted by using 
FACStar Plus  |  (BDIS). Ceils were cultured in 24-well plates at 37~ 
in RPMI 1640-based medium as described (24). Where indicated, 
anti-TCR-~/mAb was immobilized on plastic at 50/~g/ml in PBS 
at 4~  overnight. 
Immunofluorescence and Flow  Cytometry.  Cultured  cells  (106) 
were washed in HBSS containing 0.2% BSA and 0.1% NAN3. For 
staining, cells were first incubated with anti-FcTR mAb 2.4G2 (33) 
to block FcR-mediated binding, and then sequentially incubated 
with FITC-labeled anti-CD4 (mAb Rm4-5) and biotinylated anti- 
1 Abbreviations used in this paper: FU, fluorescence  units; PI, propidium 
iodide; TE, thymic epithelial. 
CD8 (mAb 53-6-72),  followed by Texas red-streptavidin.  Flow 
cytometry analyses were performed as described (34). The two anti- 
CD4 mAbs used for staining and for cytolytic depletion bind to 
different epitopes on CD4 and do not interfere with each other's 
binding. 
CD4 fluorescence intensity on CD8 + cells was quantitated in 
linear fluorescence units (25). Fluorescence units (FU) are the me- 
dian intensity of CD4 staining minus median intensity of control 
Leu4 staining.  Median intensity was calculated by converting me- 
dian log channel number to linear units using an empirically de- 
rived calibration curve for each logarithmic amplifier  used. 
Cell Cycle Analysis.  Cells (106) were stained with FITC-anti- 
CD8 mAb in the presence of anti-Fc3eR mAb 2.4G2, as described 
above. Cells were then incubated with hypotonic 3.4-mM citrate 
buffer containing 25/xg/ml propidium iodide (PI), 0.1% Triton 
X-100, and 0.1 mg/ml RNase A (DNase free) at 4~  overnight 
(35). Two-color flow cytometry analysis was performed by using 
a FACScan  |  (BDIS) for CD8 cell surface expression and DNA con- 
tent detected by PI. Cell cycle status on electronically gated CD8 + 
cells was analyzed by using Ceilfit software (BDIS). 
Cell Binding Analysis of TGF-~.  Cross-linking  analysis of TGF-3 
binding to cellular proteins using radiolabeled TGF-B was described 
previously (36).  Confluent monolayers of TE cell lines  were in- 
cubated with 12SI-labeled  TGF-31 (200 pM) in the absence or pres- 
ence of excess amount of unlabeled TGF-B1 (10 riM) at 37~  for 
2 h.  Proteins on washed cells were cross-linked  by using disuc- 
cinimidyl suberate (Pierce,  Rockford, IL), and cell lysates were 
resolved by 7% SDS-PAGE and analyzed by subsequent autoradi- 
ography. 
Immunohistochemical Analysis of TGF-fl Expression.  Anti-TGF-fl 
antibodies  used for immunohistochemical studies were developed 
by K. C. Flanders et al. (37-39) and raised in rabbits against:  (a) 
synthetic peptides of amino acids 1-30 of mature TGF-31; (b) syn- 
thetic peptides of amino acids 267-278 of the pro region of precursor 
TGF-31; and (c) synthetic peptides of amino acids 50-75 of mature 
TGF-32. All antibodies exhibit intracellular localization, and react 
specifically with the isoforms to which they were raised. 
For cytospin preparations,  cell cultures were harvested using a 
solution of  0.5 mM EDTA in PBS without calcium and magnesium. 
Cells were washed twice in PBS with 1 mg/ml of BSA, and then 
resuspended  in  PBS  with  BSA  at  a  concentration  of 106/ml. 
TGF-3 isoforms were localized  in cytospin preparations fixed in 
4% paraformaldehyde. 5-#m sections of thymic lobes were dissected 
from day 17 fetal, neonatal, or adult mice.  Tissues were fixed in 
10% buffered formalin and embedded in paraffin for sectioning, 
and sections were deparaffinized  before staining.  Both tissue  sec- 
tions and cytospins  were incubated in 2% hydrogen peroxide in 
methanol to block endogenous peroxidase, and then permeabilized 
with a hyaluronidase solution (1 mg/ml, Calbiochem-Novabiochem 
Corp., La Jolla, CA). Slides were blocked with 5% normal goat 
serum, and 1% BSA fraction V (Miles, Kankakee, IL) for 1 h at 
room temperature, and then incubated overnight with 3-5 tzg/ml 
of anti-TGF-/3 IgG or normal rabbit IgG in Tris-buffered  saline. 
Slides were washed with Tris-buffered saline/0.1% BSA and with 
a biotinylated goat anti-rabbit IgG followed by avidin-peroxidase. 
Slides were developed in an 0.5% solution of 3,3-diaminobenzidine 
(Sigma Chemical Co.), counterstained in Mayer's hematoxylin, and 
photographed at magnifications of either 200 or 400 using a Zeiss 
Axiophot microscope. 
The binding of rabbit anti-TGF-~ antibodies to frozen thymus 
sections was performed as previously described (40). Affinity-purified 
rabbit antibodies were diluted to final concentrations of 0.5-1/zg/rrd 
in PBS containing 10 mg/ml BSA. Polyclonal mouse anti-rabbit 
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genin and detected with sheep anti-digoxigenin Fab antibody frag- 
ments conjugated with horseradish peroxidase. Hydrogen peroxide 
and 3,3-diaminobenzidine were used to demonstrate peroxidase ac- 
tivity. 
Results 
Generation of CD4 +  CD8 + Thymocytes from CD4- CD8  '~ 
Precursor Cells Requires One Cell Division.  We began by as- 
sessing the ability of CD4-CD8 l~ precursor cells to differen- 
tiate into CD4+CD8 +  thymocytes  either in intact  thymic 
lobes or in single cell suspension culture in which they were 
not in contact with TE cells. Intact day 14 fetal thymus lobes 
that had been cultured for 5 d were either continued for an 
additional 16 h or were dispersed into single cell suspension 
cultures for an additional  16 h.  Whereas  total numbers of 
thymocytes recovered after 16 h were comparable in both sit- 
uations, the frequency of CD4+CD8 § thymocytes generated 
in  suspension culture  (61%)  was  significantly  higher  than 
that generated in intact organ cuhures (33%) (Fig. 1). Thus, 
dissociation of CD4-CD8 l~ precursor cells from intrathymic 
stromal components appeared  to augment their differentia- 
tion into  CD4 +CD8 +  thymocytes. 
To determine if precursor calls proliferated in suspension 
culture during differentiation into CD4 + CD8 + thymocytes, 
we purified CD4-CD81~  precursor ceils  from day  19 fetal 
thymuses and determined the number of starting ceils and 
the subsequent number of CD4 +  CD8 + progeny. As shown 
in Fig. 2 A, purified CD4-CD8 L~ fetal thymocytes prolifer- 
ated during suspension cuhure as their cell number increased 
1.5-fold after  16 h.  Cell cycle analysis  of precursor thymo- 
cytes at the initiation of culture revealed that 53% had a DNA 
content greater  than lx  and so were in S or G2 + M  phase 
and were actively progressing through the cell cycle (Fig. 2 
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Figure  1.  Generation  of CD4 +CD8 + cells in fetal thymic organ cul- 
ture (FTOC)  versus suspension culture.  After 5 d of culture,  day 14 fetal 
thymus lobes (FTOC, 14/5) were divided into two groups:  one group 
was dispersed into single cell suspension culture,  and the other group was 
washed but kept intact in organ culture.  Cells were then cultured for an 
additional 16 h, and analyzed for CD4 and CD8 expression by two-color 
flow cytometry.  Expression of CD4 and CD8 is displayed as dual param- 
eter contour plots with increasing FITC fluorescence on the x-axis (3 de- 
cade log scale) versus increasing  Texas red fluorescence on the y-axis (4 
decade log scale). Numbers within each box of contour diagrams indicate 
the frequency of cells within that box. Compared with starting cell numbers 
before the 16-h culture,  105%  were recovered from suspension cultures 
and 88% were recovered from thymus organ  cultures. 
B). After 16 h in suspension culture, all the cultured thymo- 
cytes  were  CD4 +CD8 +  and only 3%  had DNA  content 
greater than lx  indicating that they were no longer cycling 
(Fig. 2 B). However, it was not possible to discern if the 50% 
of precursor cells  which  were  not in cycle became  CD4 + 
CD8 §  without  cell  cycle  progression  at  all,  or  if  all 
precursor cells progressed through one cell division during 
their differentiation into CD4 +CD8 +  thymocytes.  To dis- 
tinguish between  these possibilities,  we added the mitosis 
inhibitor nocodazole (41) to the suspension cultures so that 
all cells that had entered the cell cycle would be captured in 
M phase. In the presence of nocodazole, virtually all cultured 
cells were found to be arrested  with DNA  content  of 2x 
(Fig, 2 B), indicating that virtually all precursor thymocytes 
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Figure  2.  Differentiation  of  CD4-CD8 io  precursor  cells  into 
CD4+CD8 +  thymocytes  requires  one  cell division.  (,4)  CD4-CD8  l~ 
precursor  cells were purified by cell sorting of CD4-  day  19 fetal B6 
thymocytes, and cultured  for 16 h in suspension. CD4 and CD8 expres- 
sion before and after suspension culture are displayed as dual parameter 
contour plots with increasing FITC fluorescence on the x-axis (3 decade 
log scale) versus increasing Texas red fluorescence on the y-axis (4 decade 
log scale). Relative viable cell recoveries from three experiments  are indi- 
cated.  (B) CD4-  thymocytes  from day 19 fetal B6 mice were cultured 
for 16 h in the absence or presence of 2 #M nocodazole.  After culture, 
cells were assessed for CD4 and CD8 expression by two-color flow cytom- 
etry. CD4 expression on software gated CD8+ cells is displayed as single- 
color histograms  with increasing FITC fluorescence on the x-axis (3 de- 
cade log scale). Net CD4 fluorescence intensity on CD8+ cells was quan- 
titated in linear fluorescence units (FU) such that FU =  median intensity 
of CD4 staining  -  median  intensity  of Leu4 staining.  Cells were also 
stained with FITC-anti-CD8 mAb and with PI in the presence of 0.1% 
Triton X-100. PI staining profiles of DNA in electronically gated CD8 + 
cells are displayed in linear scale, and the percentage of cells having a DNA 
content greater than lx (%S+G2+M)  is listed. Relative viable cell recov- 
eries after culture were 85  +  15%  in medium alone and 48  +- 12%  in 
the presence of nocodazole  in three  experiments. 
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Figure 3.  Cell  cycle analysis  of CD4-CD81~ 
precursor cells  cultured  with thymic  epithelial  cells 
or with TCR signals. CD4-  thymocytes  from 
day 19 fetal  B6 mice  were cultured  for 14 h in the 
absence or presence of the indicated  cell  lines,  plate- 
bound anti-TCIL-B  antibody  (H57-597), or 100 
ng/ml PMA. Nocodazole (10 #M) was added 
where indicated. After  culture, cells were stained 
with FITC-anti-CD8  mAb and with PI in the pres- 
ence of  0.1% Triton  X-100. Cell  cycle  distribution 
based on PI staining  profiles  of  DNA in electroni- 
cally  gated  CD8 + cells are displayed  in linear scale, 
and percentage  of cells in each cell cycle  phase is 
listed (% GI/S/G2  + M). 
were cycling cells that had progressed to M phase.  It is in- 
teresting to note that arrest in M phase by nocodazole also 
resulted in significantly reduced quantities of surface CD4 
levels by cultured precursor cells (Fig. 2 B). Thus, at least 
one cell division is required for complete expression of CD4 
to generate CD4hiCD8  hi thymocytes. 
TE Cells Inhibit Cell Cycle Progression and Differentiation of 
CD4-CD8 t~ Precursor Cells.  Because CD4-CD8  l~ precursor 
cells differentiated into CD4 +  CD8 + cells more efficiently in 
single cell suspension culture than within intact thymus lobes, 
we considered the possibility that interaction of precursor 
cells with TE cells might be inhibitory. Consequendy, we 
examined the effect of TE cell lines on cell cycle progression 
of precursor cells during their differentiation in suspension 
culture into CD4 § CD8 + thymocytes. At the initiation of 
culture, 52% of precursor cells were in G1 whereas the re- 
maining half were cycling with DNA content greater than 
lx  (Fig.  3,  column I).  At the conclusion of cultures in 
medium alone, 97% of thymocytes were in G1 phase with 
DNA content of lx, having completed one cell cycle as verified 
by nocodazole treatment in which 90% of ceils were found 
frozen with DNA content of 2 x  (Fig. 3, column 2). Similar 
results were observed at the conclusion of cultures that con- 
tained the L cell fibroblast DAP.3, platebound anti-TCR-fl 
mAb, or the phorbol ester PMA (Fig. 3, columns 5-7), indi- 
cating that none of these treatments affected cell cycle progres- 
sion of precursor cells. In contrast, results were significantly 
different in cultures containing the TE cell lines TEPI-1 or 
1308.1 (Fig. 3, columns 3 and 4). At the conclusion ofcocul- 
tures with either TEPI-1 or 1308.1, >30% of precursor cells 
had DNA content greater than lx, and 12% or fewer were 
frozen in M phase by nocodazole, indicating that the majority 
of cultured precursor cells had not completed one cell cycle. 
However, the most profound effect of TEPI-1  and 1308.1 
cell lines was that they inhibited precursor cells that were 
in G1 at the initiation of culture from progressing beyond 
G1,  as "~50% of precursor cells were found in G1 even in 
the presence  of nocodazole (Fig.  3,  column 3  and 4). 
To assess the effect of TE cell lines on differentiation of 
CD4- CD81~ precursor cells into CD4 +  CD8 + thymocytes, 
we examined their effect on induction of CD4 expression 
by cultured precursor cells. The TE cell lines that inhibited 
cell cycle progression of precursor cells (TEPI-1 and 1308.1) 
also inhibited their expression of CD4 (Fig. 4). In contrast, cell 
lines that did not inhibit their progression through the cell 
cycle,  such as the L  cell  line DAP.3  and the keratinocyte 
cell line PAM212,  interfered with neither their expression 
of CD4 nor their differentiation into CD4 § CD8 + thymo- 
cytes (Fig.  4). 
Together these results indicate that the TE cell lines TEPI-1 
and 1308.1 arrested most CD4-CD81~ precursor cells at the 
G1 stage of the cell cycle, delayed progression of precursor 
cells already in cycle,  and, as a consequence, delayed the differen- 
tiation of precursor cells into CD4 +  CD8 § thymocytes. 
Characterization  of Inhibitory  TE  Cells.  The  inhibitory 
TEPI-1 and 1308.1 TE cell lines are both considered to be 
of thymic cortical rather than medullary origin (26, 29). Con- 
sequently, we wished to determine if the ability to regulate 
the differentiation of CD4-CD81~ precursor cells into CD4 + 
CD8 § thymocytes was also a function of other cortical TE 
cell lines. We found that a third independently derived cor- 
tical TE ceil line, TEC (27), similarly inhibited CD4 expres- 
sion by cultured CD4-CD8 l~ precursor  cells  (Fig.  4).  In 
contrast, four medullary TE cell lines Z172, Z199R, TE-71, 
and Z210 (30),  had no inhibitory activity at all (Fig. 4 and 
data not shown). 
To begin to characterize the inhibitory molecule(s) expressed 
by cortical TE cells, we wished to determine if the inhibi- 
tory molecule(s) was membrane bound or secreted. We found 
that treatment of the inhibitory TE cell line 1308.1 with 
trypsin removed its inhibitory ability, suggesting that the 
inhibitory molecule(s) was a membrane-bound protein (Table 
1). Consistent with this conclusion, we also found that su- 
PAM212  -~  TE71 
TE.,,  =ll  I 
/  'L  ~,/zj72  r 
CD4 Expression on CD8 t  Cells 
Figure 4.  Effect  of various  ad- 
herent cell  lines on the differenti- 
ation of CD4- CD8  lo precursor 
cells into CD4+CDS+ thymo- 
cytes. CD4-  thymocytes  from 
day 19 fetal  B6 mice  were  cultured 
for 16 h in the absence or pres- 
ence of confluent monolayers  of 
the indicated  cell  lines. Cells  were 
assessed  for CD4 and CD8 expres- 
sion before  and after  culture as in- 
dicated, with CD4 expression  on 
software gated CD8 + cells dis- 
played as single-color  histograms 
with increasing  FITC  fluorescence 
on the x-axis (3 decade  log scale). 
The presence of monolayer  cells 
did not affect  viable  cell  recovery. 
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contain  any inhibitory  activity (Table  1). 
Cell  Cycle  Progression  and  Differentiation  of CD4-CD8 t~ 
Precursor Cells Can Be Inhibited by TGF-fl.  Because our results 
indicated that cortical TE cells inhibited  the differentiation 
of CD4- CD81~ precursor  cells  into  CD4 + CD8 +  thymo- 
cytes by primarily affecting their ability to progress through 
the cell cycle, we focused our attention  on molecules  that 
can regulate cell cycle progression and that can be expressed 
on  cell  membranes.  TGF-/3  is  known  to  arrest  cell  cycle 
progression at G1 in many cells (42-44). And, whereas TGF-B 
is a soluble cytokine, it can also be bound to cell membranes 
by a  membrane-associated/3-glycan  (36,  45,  46). 
Consequently,  we examined the effect of TGF-/31 on cell 
cycle  progression  of cultured  CD4-CD81~  precursor  cells 
(Table 2). At the initiation of culture, 52% of precursor cells 
were in G1.  Nocodazole  treatment  revealed that  only 9% 
remained in G1 at the conclusion of cultures with medium 
alone, indicating that the vast majority of precursor cells had 
entered the cell cycle during the culture. In contrast, nocoda- 
zole treatment of TGF-B1 treated cultures revealed that 42% 
of precursor cells remained in G1 at the conclusion  of cul- 
ture, indicating  that TGF-/31 inhibited  most precursor cells 
from progressing beyond G1 (Table 2). These results demon- 
strate that, like cortical TE cells, TGF-/31 can arrest cell cycle 
progression  of CD4-CD81~ precursor  cells  at G1. 
Next, we examined the effect of TGF-/~ on the differentia- 
Table  2.  Cell Cycle Analysis  of CD4-CD8 l~ Precursor Cells 
Cultured with  TGF-~ 
Cell cycle distribution  of CD8 + cells 
Suspension culture  No nocodazole  Nocodazole 
Time  Added  reagent  G1  S  G2+M  G1  S  G2+M 
h 
0  -  52*  34  14 
14  Medium  97  2  1  9  1  91 
14  TGF-/81  85  13  2  42  21  37 
CD4-  thymocytes from day 19 fetal B6 mice were cultured  for 16 h 
in the absence or presence of I  ng/ml TGF-/31. Nocodazole (10/~M) 
was added where indicated. After culture, cells were stained with FITC- 
anti-CD8 mAb and with PI in the presence of 0.1% Triton X-100. The 
cell cycle distribution based on PI staining profiles of DNA in electroni- 
cally gated CD8 + cells were analyzed by flow cytometry. 
* Percentage,of total CD8 + cells. 
tion  of precursor  cells into  CD4+CD8 §  thymocytes  (Fig. 
5). TGF-/31, TGF-/32, and TGF-~3 each inhibited the differen- 
tiation of CD4-CD81~ precursor cells. In contrast, no other 
cytokine tested showed any inhibitory effect, including  IL- 
lot,  IL-2,  IL-3,  IL-4,  IL-5,  IL-6,  IL-7,  IL-8,  IFN-%  and 
Table  1.  The Inhibitory Ligand Expressed on Cortical TE cells is a Membrane-bound Protein 
Suspension culture of 
CD4-  fetal thymocytes* 
CD4 Expression 
Time in  Added cell  Treatment of  on CD8 + cells 
Expt.  culture  lines  added cell lines~  (FU)S  Inhibitionll 
h 
0  -  16 
14  None  145 
14  1308.1  Medium  34 
14  1308.1  Trypsin  147 
0  -  17 
14  None  234 
14  TEC  142 
14  TEC supernatant  234 
% 
86 
0 
42 
0 
* CD4-  thymocytes (0.5  x  106/culture) from day 19 fetal B6 mice were cultured for 14 h in the absence or presence of the indicated cell lines 
(10% Where indicated, cultures included supernatant (final concentration at 50% vol/vol)from confluent TEC cell line. 
* Cell lines were pretreated with trypsin (0.5 mg/ml in 0.2 mg/ml EDTA; GIBCO BILL, Gaithersburg,  MD) for 10 min at 37~  and washed 
thoroughly. 
S Cells were assessed for CD4 and CD8 expression at the conclusion of culture. CD4 expression on CDS+ cells is displayed as net CD4 fluorescence 
intensity expressed in linear fluorescence units (FU), where FU  =  median intensity of CD4 staining -  median intensity of control staining. Median 
intensity was calculated by converting median log channel number to linear units using an empirically derived calibration curve for each logarithmic 
amplifier used. 
II Percent inhibition of CD4 expression was calculated as follows: 100  x  [(FU of cultured cells with medium alone -  FU of experimental groups)/(FU 
of cultured cells with medium alone  -  FU of uncultured precursor cells)]. 
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Figure 5.  Effect  of  recombinant  soluble  cytokines  on the in vitro differen- 
tiation of CD4-CD81~ precursor cells into CD4 +  CD8 + thymocytes. 
CD4- thymocytes  from day 19 fetal B6 mice were cultured for 16 h in 
the absence or presence of the indicated  recombinant cytokines.  At the 
conclusion of culture, cells were assessed for CD4 and CD8 expression 
with CD4 expression on software  gated CD8 + cells  displayed  as single- 
color histograms  with increasing  FITC fluorescence  on the x-axis (3 de- 
cade log scale). Concentration  of  cytokines  used  was 10 ng/ml for human 
TGF-/~I, TGF-fl2,  TGF-33, and mouse  TNF-cq and 20 ng/ml for human 
IL-8. 
TNF-ol. The effects of TNF-ot and IL-8 are displayed as rep- 
resentative of cytokines without inhibitory effect (Fig.  5). 
Thus,  soluble TGF-3 also mimicked the inhibitory effects 
of cortical TE  cell  lines  on  the  differentiation of CD4- 
CD81~ precursor cells. 
Inhibitory  Effect  of  TGF-fl  is  Specific for  CD4-CD81~ 
Precursor Cells.  To determine if soluble TGF-j8  also inter- 
feted with the preceding developmental step, namely the gener- 
ation  of CD4-CD81~ precursor  cells  from  CD4-CD8- 
thymocytes, we dispersed untreated and unfractionated day 
15 fetal thymocytes into single cell suspension cultures for 
16 h in the presence or absence of soluble TGF-fll (Fig. 6). 
Because of the early (i.e., day 15) gestational age of fetal thymo- 
cytes used in this experiment, 98%  of cells were initially 
CD4-CD8-  with  many differentiating into  CD8 +  cells 
during  16-h  suspension  culture  so  that  they were  either 
CD4-CD81~ or CD4+CD8 + (Fig.  6,  left and center). It is 
interesting that soluble TGF-~/1 did not interfere with the 
differentiation of CD4- CD8 -  cells into CD8 + thymocytes 
as the percentage of CD8 + cells was the same in medium 
(37%) or TGF-fll (35%) (Fig. 6, center and right). However, 
at  the end of culture in TGFq~I,  more cells were CD4- 
CD81~ and fewer were CD4+CD8 +  . In medium alone three 
quarters  of the CD4-CD8-  cells  that  differentiated into 
CD8 + cells during the 16-h culture differentiated all the way 
to the CD4 +  CD8 + stage.  In contrast, in the presence  of 
TGF-fll,  three  quarters  of the  cells  that  became  CD8 + 
during culture remained at the CD4-CD8 t~ stage of devel- 
opment,  with  only  one  quarter  becoming  CD4+CD8 + 
(Fig.  6). Thus, soluble TGF-fl is not inhibitory of all steps 
in early thymocyte differentiation as it does not inhibit the 
differentiation of CD4-CD8-  thymocytes into CD4-CD81~ 
0hr 
Recovered 
Cells x 10  .6  1.9 
|2  I  ~  I 
[  I  I  I 
16 hr  16 hr 
Med  TGF - ]31 
1.2  1.3 
lO  t 
CD4 
Figure  6.  TGF-/~  does not effect the differentiation  of CD4-CD8- 
thymocytes  into CD4-CD81~  cells. Unfractionated  day 15 fetal thymo- 
cytes  were  placed  in single  ceU suspension  cultures  at 37~  in either  medium 
alone or in the presence of recombinant TGF-/~I (1 ng/ml). After 16 h 
of culture, cells were assessed  for CD4 and CD8 expression  by two-color 
flow  cytometry.  CD4 and CD8 expression  are displayed  as dual  parameter 
contour plots with increasing  FITC fluorescence  on the x-axis (3 decade 
log scale) versus increasing  Texas red fluorescence  on the y-axis  (4 decade 
log scale). The number  of recovered  cells  are indicated  and were not affected 
by the presence or absence of TGF-/31. 
precursor cells, although it does interfere with the subsequent 
differentiation of CD4-CD8 l~ precursor  cells into CD4 + 
CD8 + thymocytes. 
TGF-fl is Expressed by Inhibitory Cortical TE Cells.  Because 
the inhibitory effect of TGF-3 was specific for CD4-CD81~ 
precursor cells and so closely resembled that of cortical TE 
cells, we wondered if TGF-3 could bind to the surface of 
TE cells and function as a membrane-bound inhibitory mol- 
ecule.  Indeed,  we found that radiolabeled  TGF-31  could 
specifically bind to the surface of both inhibitory (TEPI-1 
and TEC) and noninhibitory (Z199R) TE cell lines to form 
a high molecular weight complex with a membrane protein, 
presumably 3-glycan (Fig.  7). It is interesting to note that 
when pulsed with TGF-fll, medullary Z199R cells inhibited 
the  differentiation of CD4-CD8 lo precursor  cells  to  the 
same extent as inhibitory cortical TEPI-1 cells (Table 3, groups 
1-5).  The ability to confer an inhibitory potential on Z199R 
cells was dependent upon the expression of a membrane pro- 
tein capable of binding TGF-fl, as trypsinization of Z199R 
cells before TGF-B1 pulsing prevented the cells from becoming 
inhibitory (Table 3,  group  7).  Similarly,  trypsinization of 
Z199R cells that had previously been pulsed with TGF-31 
reversed its inhibitory activity (Table 3, group 8). Thus, TGF-3 
can bind to the membrane of TE cells and, when present 
on the surface of TE cells, does function to inhibit the differen- 
tiation of precursor cells into CD4 +  CD8 + thymocytes. 
We then wished to use neutralizing anti-TGF-fll antibodies 
to determine if membrane-bound TGF-31 molecules were 
the inhibitory molecule(s) expressed on the surface of inhibi- 
tory cortical TE cells. Unfortunately, we found that anti- 
TGF-31 antibodies were unable to neutralize the inhibitory 
activity of membrane-bound TGF-~/1 even though they could 
neutralize soluble TGF-fll molecules (Fig.  8),  presumably 
because antibody epitopes were obscured by TGF-31 binding 
to membrane proteins. Specifically,  we found that anti-TGF-31 
antibodies reversed inhibition of CD4 expression induced by 
soluble TGF-31, but did not affect inhibition of CD4 ex- 
pression induced by TGF-fll-pulsed medullary Z199R cells 
1500  Developmental  Regulation  by Thymic  Epithelial Cells Expressing TGF-B Figure 7.  Binding of TGF-B to thymic epithelial cell lines. Monolayers 
of indicated TE cell lines were incubated with 12SI-labeled  TGF-B1 in the 
absence (-) or presence (+) of unlabeled competitor TGF-/31. Cell sur- 
face proteins were cross-linked by using disuccinimidyl  suberate, and cell 
lysates were resolved by SDS-PAGE and analyzed by subsequent autoradi- 
ography. (Arrow) The major TGF-Bl-associated complex,  with the mo- 
lecular weight of/~-glycan (36,  46).  These bands  were not observed in 
the presence of unlabeled competitor TGF-B1, indicating  that the com- 
plexes were specific for TGF-/3. Bands detected  at molecular  weight of 
approximately 25,000 represent cross-linked dimers of TGF-~I molecules. 
(Fig. 8, groups 2 and 7). In addition, anti-TGF-31 antibodies 
were specific for soluble TGF-31 and could not reverse inhi- 
bition induced by soluble TGF-32 and TGF-33 when these 
TGF-3 forms were also present  (Fig.  8,  group 3). 
Consequently, we directly examined whether inhibitory 
TE cell lines expressed TGF-/~ by immunohistochemical anal- 
ysis. In these experiments, we stained all fixed cells with rabbit 
antibodies specific for: (a) the latent form of TGF-~I; (b) the 
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Figure 8.  Effect of anti-TGF-B1 antibodies  on the ability of TE cells 
to regulate  in vitro thymocyte differentiation.  CD4-  thymocytes  from 
day 19 fetal B6 mice were cultured for 14 h in the absence (unfilled  bars) 
or presence (filled  Mrs) or anti-TGF-B1 antibodies.  Cultures also included 
either soluble  TGF-3 or TE cell lines  as indicated.  Z199R  cells were 
pretreated  with either TGF-/~I or medium alone (Mock). After culture, 
cells were assessed for CD4 and CD8 expression with CD4 expression 
on software gated CD8 + cells determined  in linear FU. Results  are dis- 
played as percent inhibition of CD4 appearance (see Table 1). Soluble recom- 
binant TGF-/~I,  TGF-B2,  and  TGF-B3 were added at 10 ng/ml each. 
mature form of TGF-~I;  (c) the mature form of TGF-B2; 
and (d) the mature form of TGF-~3.  All three inhibitory cor- 
tical TE cell lines were stained positively with antibodies 
specific for TGF-B1 and TGF-/32, but were not stained with 
antibodies specific for TGF-B3. Staining with anti-TGF-~2 
antibodies is displayed in Fig. 9 (C-E). In contrast,  staining 
of noninhibitory medullary TE cell lines, such as Z199R, and 
the L cell line DAP.3 was dearly negative with all anti-TGF-B 
Table  3.  Effects of Pulsing Noninhibitory Medullary TE  Cell Lines with  TGF-fl 
Group 
Suspension  culture  of CD4-  fetal thymocytes* 
Added cell lines* 
Time in  CD4  expression 
culture  Name  1st  treatment  2nd  treatment  on  CD8 +  cells*  Inhibition * 
h 
1  0  -  -  -  17 
2  14  -  -  -  234 
3  14  TEPI-1  -  -  160 
4  14  Z199P,  Medium  Medium  236 
5  14  Z199R  TGF-~I  -  152 
6  14  Z199R  Trypsin  -  233 
7  14  Z199R  Trypsin  TGF-B1  234 
8  14  Z199R  TGF-~I  Trypsin  234 
% 
34 
0 
38 
0 
0 
0 
* Suspension culture of CD4- fetal precursor  thymocytes, measurement  of CD4 expression  on CD8 + cells in linear FU, and calculation  of percent 
inhibition were carried  out as described  in Table 1. 
* Cell lines were pretreated  with trypsin  for 10 min at 37~  or pulsed with 10 ng/ml TGF-~I for 30 min at 37~  followed by three  washings. 
Where indicated,  cells were trypsinized  and  pulsed  with TGF-B1 in the indicated  sequence. 
1501  Takahama  et al. antibodies (Fig.  9, A  and B), as was staining of thymocytes. 
Thus, the inhibitory ability of TE cell lines correlated with 
their expression of TGF-fll  and TGF-fl2 proteins. 
In situ Expression of TGF-I] by Cortical TE Cells.  Finally, 
to relate our in vitro studies of TE cells to the in vivo situa- 
tion within the intact thymic environment, we performed 
immunohistochemical studies on both fixed and frozen thymic 
sections from day 16-17 fetal, newborn, and young adult mice 
to determine if TGF-fl proteins are expressed by intact thymic 
epithelium in the thymus. Thymic sections were stained with 
rabbit anti-TGF-fll (latent form), rabbit anti-TGF-fll (ma- 
ture form), rabbit anti-TGF-fl2 (mature form), and rabbit 
anti-TGF-fl3 (mature form). Staining of  both fixed and frozen 
thymic  sections  with  anti-TGF-fl  antibodies  was  similar 
regardless of the age of the mouse from which the thymic 
sections were obtained. Positive staining was observed with 
anti-TGF-fll and anti-TGF-fl2 antibodies, but not with anti- 
TGF-fl3 antibodies. Fig. 10 displays staining of fixed thymic 
sections from newborn mice with anti-TGF-fl2 and control 
antibodies, and reveals TGF-fl expression in the subcapsular 
and cortical areas of the thymus which are precisely the areas 
of the thymus in which CD4- CD8  l~ precursor cells are lo- 
cated (4). To better visualize expression of TGF-fl by thymic 
stromal  cells,  we  also  stained  frozen  sections  of unfixed 
thymuses with anti-TGF-fll and anti-TGF-fl2 antibodies. Fig. 
11 displays  staining of frozen thymic sections from young 
adult mice with anti-TGF-fll, anti-TGF-fl2, and control an- 
tibodies.  As can be seen, TGF-fll  and TGF-fl2 expression 
was observed primarily by subcapsular and cortical epithelial 
cells, which are precisely the TE cells that contact immature 
Hgure 9.  Expression  of TGF-fl by TE cell lines as determined  by immunohistochemical  analysis.  DAP.3 (A), Z199R (B), TEPI-1 (C), 1308.1 (D), 
and TEC (E) were assessed  for TGF-fl expression. The indicated  cell lines were all stained with hematoxylin  and with rabbit antibodies specific  for 
TGF-fll (latent form), TGF-fll (mature  form), TGF-fl2 (mature  form), or with control  rabbit antibodies. All three rabbit anti-TGF-fl  antibodies  gave 
identical results. The results of staining with rabbit anti-TGF-fl2  (mature  form) are displayed.  Antibody  binding was visualized  by indirect  peroxidase 
staining. None of the cell lines stained with control rabbit antibodies. 
1502  Developmental  Regulation by Thymic Epithelial Calls Expressing TGF-fl CD4-CD81~  precursor  cells  in  the  thymus  (4).  Thus, 
TGF-B1 and TGF-/32  are expressed in the intact thymus by 
thymic epithdium where they can contact developing CD4- 
CD8  l~ precursor cells and regulate their progression through 
the cell cycle and, consequently, their further differentiation 
into CD4 +CD8 + thymocytes. 
Discussion 
This  study demonstrates that  the rote at  which CD4- 
CD81~ precursor cells  progress  through  the cell cycle and 
differentiate into  CD4+CD8 + thymocytes is regulated by 
interaction with cortical TE cells expressing TGF-fl proteins. 
Moreover, TGF-fl proteins themselves, either in solution or 
bound to cell membranes, were capable of  regulating cell cycle 
progression  and  differentiation of CD4-CD81~ precursor 
cells  into  CD4 +CD8 +  thymocytes. Thus,  thymic epithe- 
lium actively regulates the rate at which immature CD4- 
CD81~ thymocytes become CD4 +  CD8 +. 
The  majority of cells  in  the  thymus  are  CD4+CD8 + 
thymocytes, whose immediate precursors are CD4-CD81~ 
cells. The differentiation of CD4- CD81~ precursor cells into 
CD4+CD8 + thymocytes was found to require at least one 
cell division, but the interaction of CD4-CD81~ precursor 
cells with cortical TE cells interfered with their progression 
beyond the G1 phase of the cell cycle. The inhibitory activity 
of cortical TE cells was found to reside in a membrane-bound 
protein, which we tried unsuccessfully  to identify by blocking 
with antibodies specific for a wide variety of known mole- 
cules expressed on thymocytes or TE cells, including adhe- 
sion and major histocompatibility molecules. We then con- 
sidered the possibility that TGF-fl might be the inhibitory 
molecule expressed by cortical TE  cells  since TGF-fl was 
known to induce cell cycle arrest at G1, it could bind to cell 
membranes, and it was expressed in developing tissues.  We 
found that soluble TGF-/3 did resemble cortical TE cells in 
its ability to inhibit both proliferation and differentiation of 
CD4-CD81~  precursor  cells.  We  also  found  that  soluble 
TGF-/3 could bind to TE cell membranes, and, when present, 
would function as a membrane-bound inhibitory molecule. 
That TGF-fl was actually expressed by inhibitory cortical TE 
cells was demonstrated by immunohistochemical staining with 
anti-TGF-B antibodies.  Finally,  we found that TGF-fl was 
primarily expressed in the intact thymus by subcapsular and 
cortical epithelial cells  that contact CD4-CD81~ precursor 
cells in the thymus. Thus, expression of TGF-fl proteins by 
cortical TE cells was consistent with their ability to regulate 
cell cycle progression and differentiation of immature precursor 
cells into  CD4 +CD8 + thymocytes. 
The  differentiation of CD4-CD81~ precursor cells  into 
CD4+CD8 + thymocytes has now been shown to be regu- 
lated by two distinct molecular mechanisms, one that speci- 
fically  regulates  differentiation  of CD4-CD81~  precursor 
cells  expressing self-reactive  TCR,  and one that  regulates 
differentiation of CD4-CD81~ precursor cells regardless of 
their TCR specificity. The first mechanism is antigen specific, 
mediated by TCR signals, and aborts the further differentia- 
tion along the CD4/CD8 developmental pathway of  precursor 
Figure 10.  In situ expression  of TGF-~ in the thymus. Fixed  thymus sections  from day 17 fetal, newborn, and young adult B6 mice were stained 
with hematoxylin  and with rabbit antibodies specific  for TGF-/31 (latent form),  TGF-/31 (mature  form),  TGF-B2 (mature  form),  or with control  rabbit 
antibodies. All three  rabbit anti-TGF-fl  antibodies gave  identical  results on all three thymus  preparations. The results  of staining  newborn  thymus  with 
rabbit anti-TGF-fl2  (mature  form) (B,  x200 magnification;  C,  x400) or control  rabbit antibodies  (.4) are displayed.  Antibody  binding was visualized 
by indirect peroxidase staining. 
1503  Takahama  et al. Figure  11.  In situ expression  of TGF-3 in the 
thymus. Thymus  frozen sections  from  young  adult 
B6 mice  were  stained  with rabbit antibodies  specific 
for TGF-31 (latent form), TGF-B2  (mature form), 
or control rabbit antibodies, and antibody  binding 
was visualized with indirect peroxidase staining. 
Similar results were  obtained  with thymus frozen 
sections from day 16 fetal and newborn mice. (a 
and d) Display  labeling with normal rabbit Ig; (b 
and e) depict  labeling  with anti-TGF-31 antibodies; 
(c and J) depict labeling with anti-TGF-~2 anti- 
bodies. (a-c) Were obtained  with a magnification 
of 500; (d-J) were obtained with a magnification 
of 1,000. Within the cortex, TGF-3I is perferen- 
tially expressed  by subcasular epithelial cells, al- 
though some  cortical  stromal  cell  processes  are also 
labeled (e). With anti-TGF-82 antibodies, the dis- 
tribution of  reaction product  was punctate  and also 
exhibited a preferential  labeling of  the subcapsular 
and outer cortical areas of the thymus. (*) Cap- 
sule; (iV/)  medulla; (arrows) reaction  product gener- 
ated by enzyme-labeled  antibodies;  (arrowheads)  en- 
dogenous peroxidase activity. 
cells expressing autoreactive TCK against intrathymic  self- 
antigens.  TCK engagement induces signals in CD4-CD8 l~ 
precursor cells that lead to the rapid elimination of mRNAs 
encoding two families of molecules: the coreceptor molecules 
CD4 and CD8, and the recombination activating molecules 
RAG-1 and RAG-2 (24). The second mechanism is described 
in this report and is mediated by TGF-3 expressing TE cells 
that  regulate  the  ability of CD4-CD81~ precursor cells  to 
progress through  the cell cycle and to become CD4 +  CD8 +. 
These two regulatory mechanisms are quite distinct as TCR 
engagement did not affect cell cycle progression, and cell cycle 
arrest did not rapidly eliminate CD4 mRNA expression  (Taka- 
hama, Y., and A. Singer, unpublished results). The existence 
of two distinct mechanisms regulating the differentiation of 
CD4-CD8 l~ precursor  cells  into  CD4+CD8 +  thymocytes 
identifies this developmental step as being tightly controlled 
during  early thymocyte development. 
TGF-3 proteins are members of a superfamily of secreted 
growth factors that  contain  a cysteine knot motif and that 
function  as  dimeric  molecules  (47).  At least  five different 
TGF-~ molecules have been identified in different species, but 
only TGF-B1, -~2, and -83 have been found in mammalian 
cells (for reviews, see references 48 and 49). TGF-3 is expressed 
in early fetal tissues and has been suggested as a potentially 
important  regulator of early development  (39, 50-52),  but 
a role for TGF-3 in regulating mammalian development has 
not previously been defined. It is interesting  that we found 
that TGF-3 expressing TE cells determine the rate at which 
CD4 §  + thymocytes are generated,  for it has been sug- 
gested that TGF-B (in the presence of IL-7) induces CD4- 
CDS-  thymocytes to express CD8 (9, 53), and it is gener- 
ally thought that TE cells provide an inductive environment 
for T  cell development (15,  17, 26, 28, 54). However, con- 
trol of the rate at which CD4+CD8 + thymocytes are gener- 
ated might be important for subsequent developmental events 
in the thymus, such as selection of the T  cell repertoire.  In- 
deed,  without  TGF-3,  CD4+CD8 + thymocytes might  be 
generated  too rapidly for autoreactive cells  to be appropri- 
ately screened out in  the  thymus.  It is interesting  to note 
that whereas the basis for the pathology is not yet known, 
TGF-3I-  mice whose TGF-fll gene loci were disrupted by 
homologous recombination do suffer from an apparent  au- 
toimmune disorder with massive lymphocyte infiltration of 
multiple organs and early death (55). Unfortunately, our at- 
tempts  to  use  TGF-~/1-  mice  to  assess  the  generation  of 
CD4 +  CD8 + thymocytes in the absence of TGF-/$1 proteins 
have  so  far  been  unsuccessful  because  of the  presence  of 
maternal TGF-fl proteins during early life which is then fol- 
lowed by the rapid onset of disease and stress-induced thymic 
atrophy. 
Regulation of cell cycle progression by TGF-B has been 
extensively analyzed but is still not completely understood. 
It is thought  that  TGF-B inhibits  cyclin E  assembly with 
cyclin-dependent kinase 2, and that this assembled complex 
functions to phosphorylate retinoblastoma protein that is re- 
quired  for  progression  beyond G1  phase  of the  cell cycle 
1504  Developmental  Regulation by Thymic Epithelial Cells Expressing TGF-3 (42-44). The present study demonstrates that TGF-B is bio- 
logically active in regulating cell cycle progression of precursor 
thymocytes even when bound to the surface of TE cells. Its 
binding to TE cells was found to be specific as it was com- 
peted with cold TGF-B, and it formed a high molecular weight 
protein complex on the cell surface that resembled/~-glycan, 
a ubiquitous TGF-~ binding protein. Thus, the binding of 
TGF-/~ to ~-glycan effectively converts it into a membrane- 
bound cell interaction molecule on cortical TE cells. A prece- 
dent for conversion of soluble molecules into functional cell 
interaction molecules has recently been suggested for proteo- 
glycan-immobilized macrophage inflammatory protein  1B 
which induces T cell adhesion to vascular cell adhesion mol- 
ecule 1 and so can potentially attract T cells to inflammatory 
tissues  (56). 
In conclusion, this study demonstrates that TGF-~ pro- 
teins are expressed by thymic epithelial cells  that  contact 
CD4-CD8  l~ precursor cells developing in the thymus and 
regulate the rate at which they can differentiate into CD4 § 
CD8 §  thymocytes. 
We thank Drs. Takashi Suda and Anita Roberts for helpful discussion; Dr. Kathleen Flanders for develop- 
ment and characterization of anti-TGF-3 antibodies; and Drs. K. Katz, M. Kuehn, J. Punt, S. Sharrow, 
D. Singer, and M. Zauderer for critically reading the manuscript. 
This work was supported in part by grants from the National  Institutes of Health (AI-24137 and AG- 
04360) and the Department of Energy (DE F006-ER60409). 
Address correspondence to Dr. Alfred Singer, Experimental Immunology Branch, National Cancer Insti- 
tute, National Institutes of Health, Building 10, Room 4B17, Bethesda, MD 20892. Y. Takahama is cur- 
rently at the Institute  of Immunology,  Syntex Research, Niihari,  Ibaraki 300-41, Japan. 
Received for publication 18 October 1993 and in revised  form  31 January  1994. 
References 
1.  Fowlkes, B.J., and D.M. Pardoll. 1989. Molecular and cellular 
events of T cell development. Adv. Immunol. 44:207. 
2.  Scollay, R., A. Wilson,  A. D'Amico, K. Kelly, M. Egerton, 
M. Pearse, L. Wu, and K. Shortman.  1988. Developmental 
status and reconstitution  potential of subpopulations of mu- 
fine thymocytes. Immunol. Rev. 100:81. 
3.  Husmann,  L.A., R.P.  Shimonkevitz, I.N. Crispe, and M.J. 
Bevan. 1988. Thymocyte  subpopulations during early fetal de- 
velopment in the BALB/c mouse. J. Immunol. 141:736. 
4.  Paterson, D.J., and A.F. Williams. 1987. An intermediate cell 
in thymocyte  differentiation that expresses  CD8 but not CD4 
antigen. J. Extx Med. 166:1603. 
5.  Nikolic-Zugic,  J., and M.J. Bevan. 1988. Thymocytes  expressing 
CD8 differentiate into CD4 § cells following intrathymic in- 
jection. Pro~ Natl. Acad. Sci. USA.  85:8633. 
6.  MacDonald,  H.R.,  R.C.  Budd,  and R.C.  Howe.  1988. A 
CD3-  subset of CD4-CD8 + thymocytes: a rapidly cycling 
intermediate in the generation  of CD4+CD8 § cells. Eur. J. 
Immunol. 18:519. 
7.  Shortman,  K., A. Wilson,  M. Egerton, M. Pearse, and R. 
Scollay. 1988. Immature CD4-CD8 + murine thymocytes. 
Cell Immunol. 113:362. 
8.  Guidos, C.J., I.L. Weissman, and B. Adkins. 1989. Intrathymic 
maturation of murine T lymphocytes from CD8 § precursors. 
Proc. Natl. Acad. Sci. USA.  86:7542. 
9.  Suda, T., and A. Zlotnik. 1992. In vitro induction  of CD8 
expression on  thymic  pre-T cells. I.  Transforming growth 
factor-B and tumor necrosis factor-cr induce CD8 expression 
on CD8- thymic subsets including the CD25§  - 
CD8-  pre-T cell subset. J. Immunol. 148:1737. 
10.  Kappler, J.W., N. R.oehm, and P. Marrack. 1987. T cell toler- 
ance by clonal elimination in thymus. Cell. 49:273. 
(Lond.). 356:718. 
20.  Molina, T.J., K. Kishihara, D.P. Siderovski, W. van Ewijk, 
A.  Narendran,  E. Timms,  A. Wakeham, C.J.  Paige, K.-U. 
Hartmann, A. Veillette, et al. 1992. Profound block in thymo- 
11.  Fowlkes, B.J., R.H. Schwartz, and D.M. Pardoll. 1988. Dele- 
1505  Takahama  et al. 
tion of self-reactive  thymocytes occurs at a CD4+8 § precursor 
stage. Nature (Lond.). 334:620. 
12.  Sha, W.C., C.A. Nelson, R.D. Newberry, D.M. Kranz, J.H. 
Russell, and D.Y. Loh. 1988. Positive and negative selection 
of an antigen receptor on T cells in transgenic mice. Nature 
(Lond.). 336:73. 
13.  Teh, H.S., P. Kisielow, B. Scott, H. Kishi, Y. Uematsu,  H. 
Bluthman,  and  H.  yon  Boehmer.  1988. Thymic  major 
histocompatibility complex antigens and the ~3 T-cell  receptor 
determine the CD4/CD8 phenotype oft cells. Nature (Lond.). 
335:229. 
14.  Shortman, K., D. Vremec, and M. Egerton. 1991. The kine- 
tics of T  cell antigen  receptor expression by subgroups  of 
CD4 §  8 § thymocytes: delineation of CD4 §  8 §  32 § thymocytes 
as post-selection  intermediates leading to mature T cells.J. Exp. 
Med. 173:323. 
15. Jenkinson, E.J., G. Anderson, and J.J.T. Owen. 1992. Studies 
on T cell maturation  on defined thymic stromal cell popula- 
tions in vitro. J. Ex  F Med. 176:845. 
16.  Swat, W., M. Dessing, A. Baron, P. Kisielow, and H. von 
Boehmer. 1992. Phenotypic changes accompanying positive se- 
lection of CD4 +  CD8 + thymocytes. Eur.  J. Immunol. 22:2367. 
17.  Kaye,  J., and D.L. Ellenberger. 1992. Differentiation of an im- 
mature T cell line: A model of thymic positive selection. Cell. 
71:423. 
18.  Borgulya, P., H. Kishi, Y. Uematsu,  and H. yon Boehmer. 
1992. Exclusion and inclusion of ~  and fl T cell receptor al- 
leles. Cell. 69:529. 
19.  Seong,  R.H.,J.W. Chamberlain, andJ.R. Parnes. 1992. Signal 
for T-cell differentiation to a CD4 cell lineage is delivered by 
CD4 transmembrane region and/or cytoplasmic tail. Nature 
cyte development in mice lacking p56  lck. Nature (Lond.). 356: 
161. 
21.  Appleby, M.W., J.A. Gross, M.P. Cooke, S.D. Levin, X. Qian, 
and R.M. Perlmutter. 1992. Defective T cell receptor signalling 
in mice lacking the thymic isoform of p59  ~. Cell. 70:751. 
22.  Chan, S.H., D. Cosgrove, C. Waltzinger, C. Benoist, and D. Mathis. 1993. Another view of the selective  model of thymo- 
cyte selection. Cell.  73:225. 
23. Davis, C.B., N. Killeen, M.E. Casey  Crooks, D. Raulet, and 
D.K. Littman. 1993. Evidence for a stochastic mechanism in 
the differentiation of mature subsets of T lymphocytes. Cell. 
73:237. 
24.  Takahama,  Y., and A. Singer. 1992. Post-transcriptional regu- 
lation of early T cell development by T cell receptor signals. 
Science (Wash. DC).  258:1456. 
25.  Takahama,  Y., E.W. Shores, and A. Singer. 1992. Negative se- 
lection of precursor thymocytes  before their differentiation  into 
CD4+CD8 + cells. Science (Wash. DC).  258:653. 
26.  Beardsley,  T.R., M. Piercshbacher, G.D. Wetzel, and E.F. Hays. 
1983. Induction of T-cell maturation by a cloned line of thymic 
epithelium (TEPI). Proa Natl. Acad.  Sci. USA.  80:6005. 
27.  Glimcher, L.H., A.M. Kruisbeek, W.E. Paul, and I. Green. 
1983. Functional activity of a transformed thymic epithelial 
cell line. Scand. J. Immunol.  17:1. 
28.  Vukmanovic, S., A.G. Grandea III, S.J. Faas, B.B. Knowles, 
and M.J. Bevan. 1992. Positive selection of T-lymphocytes  in- 
duced by intrathymic injection of a thymic epithelial cell line. 
Nature (Lond.). 259:729. 
29.  Faas, S.J., J.L. Rothstein, B.L. Kreider, G. Rovera, and B.B. 
Knowles. 1993. Phenotypically diverse mouse thymic stromal 
cell lines which induce proliferation and differentiation of he- 
matopoietic cells. Eur. J. Immunol.  23:1201. 
30.  Farr, A.G., S. Hosier, S.C. Braddy, S.K. Anderson, D.J. Eisen- 
hardt, Z.J. Yah, and C.P. gobles.  1989. Medullary epithelial 
cell lines from murine thymus constitutively secrete 1I--1 and 
hematopoietic growth factors and express class II antigens in 
response to recombinant interferon-% Cell. Immunol.  119:427. 
31.  Yuspa, S.H., P. Hawley-Nelson, B. Koehler, andJ.R. Stanley. 
1980. A survey of transformation markers in differentiating 
epidermal cell lines in culture. Cancer Res.  40:4694. 
32.  Wiglet, M., A. Pellicer, S. Silverstein, g. Axel, G. Urlaub, 
and L.  Chasin.  1979. DNA-mediated transfer of adenine- 
phosphoribosyl transferase locus into mammalian cells. Pro~ 
Natl. Acad.  Sci. USA.  76:1373. 
33.  Unkeless, J.C.  1979. Characterization of a monoclonal anti- 
body directed against mouse macrophage and lymphocyte Fc 
receptors. J. Exp. Med.  150:580. 
34.  Takahama, Y., S.O. Sharrow, and A. Singer. 1991. Expression 
of an unusual T cell receptor V3 repertoire by Ly-6C  + sub- 
populations of CD4 + and/or CD8 + thymocytes. Evidence for 
a developmental  relationship between Ly-6C  + thymocytes and 
CD4-CD8-TCRoe3 + thymocytes. J. Immunol.  147:2883. 
35.  Brons, P.P., A.H. Pennings, C. Haanen, H.M. Wessels, and 
J.B. Boezeman. 1990. Simultaneous  measurement  of  DNA con- 
tent  and  cell-surface immunofluorescence of human  bone 
marrow cells using a single laser flow cytometer. Cytometry. 
11:837. 
36.  Wang, X.-F.,  H.Y. Lin, E. Ng-Eaton, J. Downward,  H.F. 
Lodish, and R.A. Weinberg. 1991. Expression  cloning and char- 
acterization of the TGF-3 type III receptor. Cell.  67:797. 
37.  Flanders,  K.C.,  N.L.  Thompson,  D.S. Cissel,  E.  Van 
Obberghen-Schilling, C.C. Baker, M.E. Kass, L.K. Ellings- 
worth, A.B. Roberts, and M.B. Sporn. 1989. Transforming 
growth factor-B1: histochemical localization with antibodies 
to different epitopes. J.  Cell Biol. 108:653. 
38.  Flanders, K.C., D.S. Cissel, L.T. Mullen, D. Danielpour, M.B. 
Sporn, and A.B. Roberts. 1990. Antibodies to transforming 
growth factor-32 peptides: specific  detection of  TGF-32 in im- 
munoassays. Growth Factors. 3:45. 
39.  Flanders,  K.C., G. Ludecke,  S. Engels, D.S. Cissel,  A.B. Roberts, 
1506 
P. Kondaiah, R. Lafyatis,  M.B. Sporn, and K. Unsicker. 1991. 
Localization and actions of transforming growth factor-Bs  in 
the embryonic nervous system. Development. 113:183. 
40.  Farr, A., A. Nelson, and S. Hosier. 1992. Characterization of 
an antigenic determinant preferentially  expressed by type I ep- 
ithelial cells in the murine thymus. J. Histochem. Cytochem. 
40:651. 
41.  Terasaki,  M., L.B. Chen, and K. Fujiwara. 1986. Microtubules 
and the endoplasmic  reticulum are highly interdependent  struc- 
tures. J.  Cell. Biol. 103:1557. 
42.  Laiho,  M., J.A. DeCaprio, J.W. Ludlow,  D.M. Livingston, and 
J. Massague. 1990. Growth inhibition by TGF-3 linked to sup- 
pression of retinoblastoma protein phosphorylation. Cell. 62: 
175. 
43.  Howe, P.H., G. Draetta,  and E.B. Leos 1991. Transforming 
growth factor 31 inhibition of p34  caa phosphorylation and 
histone H1 kinase  activity  is associated  with G1/S-phase  growth 
arrest. Mol.  Cell. Biol. 11:1185. 
44.  Koff,  A., M. Ohtsuki, K. Polyak,  J.M. Roberts, and J. Mas- 
sague. 1993. Negative regulation of G1 in mammalian cells: 
inhibition of  cyclin  E-dependent  kinase  by TGF-3. Science (Wash. 
DC). 260:536. 
45.  Anders, J.L., K. Stanley, S. Chiefetz, and J. Massague. 1989. 
Membrane-anchored and soluble forms of betaglycan, a poly- 
morphic proteoglycan  that binds transforming  growth factor-3. 
J.  Cell Biol. 109:3137. 
46.  Lopez-Casillas,  F., S. Cheifetz, J. Doody, J.L. Andres, W.S. 
Lane, and J. Massague. 1991. Structure and expression of the 
membrane proteoglycan, a component of the TGF-3 receptor 
system. Cell. 67:785. 
47.  McDonald, N.Q., and W.A. Hendrickson. 1993. A structural 
superfamily  of  growth factors  containing a cystine  knot motif. 
Cell.  73:421. 
48.  Sporn, M.B., and A.B. Roberts. 1992. Transforming growth 
factor-B: recent progress and new challenges, j.  Cell  Biol. 
119:1017. 
49.  Massague, J.  1992. Receptors for the TGF-3  family. Cell. 
69:1067. 
50.  Thompson, N.L., K.C. Flanders, J.M. Smith, L.K.  Ellings- 
worth, A.B. Roberts, and M.B. Sporn. 1989. Expression of 
transforming growth factor-31 in specific  cells and tissues of 
adult and neonatal mice. J.  Cell Biol. 108:661. 
51.  Schmid, P., D. Cox, G. Bilbe, K. Maier, and G.K. McMaster. 
1991. Differential  expression  of  TGF 31, 32 and 33 genes  during 
mouse embryogenesis. Development. 111:117. 
52.  Millan, F.A., F. Denhez, P. Kondaiah, and R.J. Akhurst. 1991. 
Embryonic gene expression patterns of TGF 31, 32 and 33 
suggest different  developmental  functions in vivo. Development. 
111:131. 
53.  Inge, T.H., K.M. McCoy, B.M. Susskind, S.K. Barrett, G. 
Zhao, and H. Bear. 1992. Immunodulatory effects of trans- 
forming growth factor-3 on T lymphocytes.  Induction of  CD8 
expression in the CTLb2 cell line and in normal thymocytes. 
J. Immunol.  148:3847. 
54. Jenkinson, E.J., and JJ.T. Owen.  1990. T-cell differentiation 
in thymus organ cultures. Seminars in Immunol.  2:51. 
55.  Kulkarni, A.B., C.-G. Hoh, D. Becket, A. Geiser, M. Lyght, 
K.C. Flanders, A.B. Roberts, M.B. Sporn, J.M. Ward, and S. 
Karlsson. 1993. Transforming  growth factor 31 null mutation 
in mice causes exizessive  inflammatory  response and early  death. 
Pro~ Natl. Acad. Sci. USA.  90:770. 
56.  Tanaka,  Y., D.H. Adams, S. Hubscher, H. Hirano, U. Sieben- 
list, and S. Shaw. 1993. T-cell  adhesion  induced  by proteoglycan- 
immobilized cytokine MIP-13. Nature (Lond.). 361:79. 
Developmental Regulation by Thymic  Epithelial Cells Expressing TGF-3 